Select status:
Sort by:
Filter by last updated date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and November 2020

Filter by type
Showing 1 to 10 of 498
Title Reference number Published Last updated
Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancer Reference number:TA660 TA00660 Published:25 November 2020 20201125 Last updated:25 November 2020 20201125
Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma Reference number:TA661 TA00661 Published:25 November 2020 20201125 Last updated:25 November 2020 20201125
Durvalumab in combination for untreated extensive-stage small-cell lung cancer (terminated appraisal) Reference number:TA662 TA00662 Published:25 November 2020 20201125 Last updated:25 November 2020 20201125
Siponimod for treating secondary progressive multiple sclerosis Reference number:TA656 TA00656 Published:18 November 2020 20201118 Last updated:18 November 2020 20201118
Carfilzomib for previously treated multiple myeloma Reference number:TA657 TA00657 Published:18 November 2020 20201118 Last updated:18 November 2020 20201118
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma Reference number:TA658 TA00658 Published:18 November 2020 20201118 Last updated:18 November 2020 20201118
Galcanezumab for preventing migraine Reference number:TA659 TA00659 Published:18 November 2020 20201118 Last updated:18 November 2020 20201118
Drug-eluting stents for the treatment of coronary artery disease Reference number:TA152 TA00152 Published:23 July 2008 20080723 Last updated:18 November 2020 20201118
Guidance on the use of coronary artery stents Reference number:TA71 TA00071 Published:22 October 2003 20031022 Last updated:18 November 2020 20201118
Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy Reference number:TA655 TA00655 Published:21 October 2020 20201021 Last updated:21 October 2020 20201021